Medical-legal risks of incident cancers after clearing colonoscopy

The American Journal of Gastroenterology
D K RexA D Feld

Abstract

Colonoscopy and polypectomy effectively reduce the incidence and mortality of colorectal cancer, but some patients present with fully developed cancers within 1-4 yr of a colonoscopy that apparently cleared the colon of neoplasia. These events may result in medical-legal action against colonoscopists, generally based on an assumption of negligent technical performance of the procedure. Alternative explanations for the development of interval cancers include variable growth rates of colorectal cancers, the inherent miss rate of the procedure even when optimal examination techniques are used, and the possibility of flat lesions that are not readily detected by standard colonoscopic techniques. This paper discusses issues relevant to reduction of medical-legal risks associated with interval cancers after clearing colonoscopy. These issues include informed consent, documentation of cecal intubation, appropriate description of preparation, documentation of examination time and technique, and attention to potential atypical neoplasms.

References

Nov 21, 1990·Journal of the National Cancer Institute·L J HixsonH Garewal
Aug 15, 1989·Cancer·S Kuramoto, T Oohara
Aug 1, 1984·Radiology·P J FeczkoL V Ackerman
Feb 1, 1982·Gastrointestinal Endoscopy·F J TedescoL R Mills
Jul 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S KudoH Kusaka
May 1, 1995·Gastrointestinal Endoscopy·E G LevineP Plumeri
May 1, 1994·Gastrointestinal Endoscopy·P A Plumeri
Dec 30, 1993·The New England Journal of Medicine·S J WinawerJ F Panish
Oct 1, 1993·Scandinavian Journal of Gastroenterology·O D JørgensenC Fenger
Mar 1, 1993·Gastrointestinal Endoscopy·P D Gerstenberger, P A Plumeri
Oct 1, 1995·Gastrointestinal Endoscopy·C S CutlerG A Lehman
Sep 1, 1996·Scandinavian Journal of Gastroenterology·G HoffM H Vatn
Feb 1, 1997·Gastroenterology·S J WinawerR J Mayer
Jun 12, 1999·Scandinavian Journal of Gastroenterology·E Thiis-EvensenM H Vatn
Jan 8, 2000·Gastrointestinal Endoscopy·D K Rex
Mar 10, 2000·The American Journal of Gastroenterology·M Kirsch

❮ Previous
Next ❯

Citations

Mar 25, 2014·World Journal of Gastroenterology : WJG·Jae Young Jang, Hoon Jai Chun
Feb 6, 2014·The American Journal of Gastroenterology·Stacy B MeneesPhilip Schoenfeld
Nov 25, 2005·Alimentary Pharmacology & Therapeutics·F B NicholsonM A Kamm
Jan 16, 2007·The American Journal of Gastroenterology·Shawn C Chen, Douglas K Rex
Dec 2, 2004·The American Journal of Gastroenterology·Srilekha Cherian, Pradip Singh
Jul 4, 2002·The American Journal of Gastroenterology·Douglas K RexUNKNOWN U.S. Multi-Society Task Force on Colorectal Cancer
May 17, 2002·The American Journal of Gastroenterology·Ihab ShehadehN Gopalswamy
Apr 20, 2004·The American Journal of Gastroenterology·Douglas K Rex, UNKNOWN ACG Board of Trustees
Jun 6, 2009·The American Journal of Gastroenterology·Andrew D Feld, Richard E Moses
Jun 8, 2004·The American Journal of Gastroenterology·Andrew D Feld
Aug 22, 2012·Nature Reviews. Gastroenterology & Hepatology·Silvia SanduleanuGerrit A Meijer
Sep 14, 2006·The American Journal of Gastroenterology·Shogo SasaoKazuaki Chayama
Feb 24, 2006·The American Journal of Gastroenterology·Florence AsliniaJean-Pierre Raufman
Apr 26, 2006·The American Journal of Gastroenterology·Douglas K Rex
Aug 28, 2004·The American Journal of Gastroenterology·Andrew D Feld
Jan 18, 2007·The American Journal of Gastroenterology·Douglas K Rex
Nov 29, 2007·The American Journal of Gastroenterology·John H Bond
Nov 24, 2004·The American Journal of Gastroenterology·Viju P DeenadayaluDouglas K Rex
Jan 5, 2002·The American Journal of Gastroenterology·I Klein
Oct 3, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Charles J Kahi, Douglas K Rex
Aug 3, 2004·The Cancer Journal·Michael Goodman, Jack S Mandel
Feb 3, 2007·Alimentary Pharmacology & Therapeutics·J BelseyD Heresbach
Jan 2, 2014·Surgical Endoscopy·Donato F AltomarePiero Portincasa
Feb 18, 2014·Current Gastroenterology Reports·Chantal M C le Clercq, Silvia Sanduleanu
Feb 9, 2005·Current Opinion in Gastroenterology·Roy M SoetiknoTakahiro Fujii
May 27, 2020·The American Journal of Gastroenterology·Pranati L PanugantiAlan H Daniels
Sep 7, 2014·Gut·S SanduleanuUNKNOWN Expert Working Group on ‘Right-sided lesions and interval cancers’, Colorectal Cancer Screening Committee, World Endoscopy O
Dec 16, 2006·World Journal of Gastroenterology : WJG·Toru HiyamaKazuaki Chayama
Aug 10, 2013·Cancer Medicine·Gottumukkala S RajuJohn R Stroehlein
Jan 23, 2016·Digestive Diseases and Sciences·Brandon SprungDanielle Marino
Nov 25, 2020·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Agustín Panadès Aran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Michael J O'BrienNational Polyp Study Workgroup
Gastrointestinal Endoscopy
Alan N Schulman
The American Journal of Gastroenterology
Michael D KappelmanJohn I Allen
The American Journal of Gastroenterology
Jun Haeng LeeEun Yoon Cho
© 2021 Meta ULC. All rights reserved